查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886296

gRNA市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、產品和服務（產品、客製化gRNA合成服務）、應用、最終用途、地區和競爭格局分類，2020-2030年預測

gRNA Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product & Services (Product, Custom gRNA Synthesis Services), By Application, By End-Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球gRNA市場規模為5.59億美元，預計2030年將以19.20%的複合年成長率成長至16.0352億美元。引導RNA（gRNA）是一種合成RNA分子，是CRISPR-Cas9基因編輯系統的關鍵組成部分，能夠精確引導Cas9核酸酶標靶特定的DNA序列進行修飾。全球gRNA市場的成長主要得益於基因編輯技術的顯著進步、全球遺傳疾病盛行率的上升導致對新型基因療法的需求增加，以及gRNA在生物醫學研究和農業領域應用範圍的不斷擴大。對生物技術研發的大量投資也進一步推動了市場擴張。

市場概覽
預測期 2026-2030
市場規模：2024年 5.59億美元
市場規模：2030年 16.0352億美元
複合年成長率：2025-2030年 19.20%
成長最快的細分市場 製藥和生物技術公司
最大的市場 北美洲

主要市場促進因素

全球gRNA市場的擴張主要得益於CRISPR-Cas基因編輯系統的廣泛應用，而gRNA分子正是這項基礎技術的關鍵組成部分。 CRISPR療法的臨床驗證和商業化進程不斷推進，正是這一應用趨勢的有力佐證。

主要市場挑戰

全球監管環境的複雜性和異質性對全球gRNA市場的成長構成重大阻礙。各國和各地區的法規差異導致產品核准流程繁瑣且往往重複，直接推高了研發成本，並延長了商業化進程。

主要市場趨勢

符合GMP標準的gRNA的出現，標誌著基因編輯技術從研究階段轉向治療產品階段的轉變，也因此對gRNA分子提出了嚴格的良好生產規範（GMP）要求。這確保了進入臨床試驗和市場應用的基因療法的安全性、純度和有效性。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球gRNA市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（科研用、GMP級）
    • 按產品和服務分類（產品、客製化gRNA合成服務）
    • 依應用領域（基因組工程、疾病模型研究、功能基因體學、表觀遺傳學、其他）
    • 按最終用途分類（製藥和生物技術公司、學術研究機構、合約生產組織和合約研究組織）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美gRNA市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲gRNA市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區gRNA市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲gRNA市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美gRNA市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球gRNA市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • System Biosciences, LLC
  • Jena Bioscience GmbH
  • Merck KGaA
  • Azenta US, Inc.
  • Takara Bio, Inc.
  • Synbio Technologies
  • Revvity, Inc.
  • Synthego Corporation

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23789

The Global gRNA Market, valued at USD 559.00 Million in 2024, is projected to experience a CAGR of 19.20% to reach USD 1603.52 Million by 2030. Guide RNA (gRNA) is a synthetic RNA molecule serving as a pivotal component within the CRISPR-Cas9 genome editing system, precisely directing the Cas9 nuclease to target specific DNA sequences for modification. The global gRNA market's growth is primarily driven by significant advancements in gene editing technologies, the increasing global prevalence of genetic disorders leading to higher demand for novel gene therapies, and expanding applications across biomedical research and agriculture. Substantial investment in biotechnology research and development further propels market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 559.00 Million
Market Size 2030USD 1603.52 Million
CAGR 2025-203019.20%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

Key Market Drivers

The global gRNA market's expansion is significantly propelled by the widespread adoption of CRISPR-Cas systems for gene editing, a foundational technology that gRNA molecules directly enable. The increasing clinical validation and commercialization of CRISPR-based therapies exemplify this adoption. For instance, according to Vertex's Q3 2024 financial report, 40 individuals have entered the treatment process for Casgevy, the first approved CRISPR-based medicine, demonstrating tangible progress in patient access and therapeutic application.

Key Market Challenges

The complex and heterogeneous global regulatory landscape represents a significant impediment to the growth of the Global gRNA Market. Diverse national and regional regulations necessitate extensive and often duplicative processes for product approval, directly escalating development costs and extending timelines for commercialization. This regulatory fragmentation consumes substantial financial and human resources, which could otherwise be directed towards scientific innovation and market penetration. The inherent uncertainty and varying requirements across jurisdictions also deter investment, particularly from smaller entities, thereby limiting the pipeline of novel gRNA-based applications.

Key Market Trends

The emergence of GMP-grade gRNA for clinical applications represents a pivotal shift as gene editing technologies transition from research to therapeutic products, necessitating stringent Good Manufacturing Practice standards for gRNA molecules. This ensures the safety, purity, and efficacy of gene therapies entering trials and the market. The escalating pipeline of gene therapy candidates directly fuels demand for high-quality gRNA manufacturing solutions.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • System Biosciences, LLC
  • Jena Bioscience GmbH
  • Merck KGaA
  • Azenta US, Inc.
  • Takara Bio, Inc.
  • Synbio Technologies
  • Revvity, Inc.
  • Synthego Corporation

Report Scope:

In this report, the Global gRNA Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

gRNA Market, By Type:

  • Research-Use
  • GMP-grade

gRNA Market, By Product & Services:

  • Product
  • Custom gRNA Synthesis Services

gRNA Market, By Application:

  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others

gRNA Market, By End Use:

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CMOs & CROs

gRNA Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global gRNA Market.

Available Customizations:

Global gRNA Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global gRNA Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Research-Use, GMP-grade)
    • 5.2.2. By Product & Services (Product, Custom gRNA Synthesis Services)
    • 5.2.3. By Application (Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Others)
    • 5.2.4. By End Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CMOs & CROs)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America gRNA Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product & Services
    • 6.2.3. By Application
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States gRNA Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product & Services
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada gRNA Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product & Services
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico gRNA Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product & Services
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Use

7. Europe gRNA Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product & Services
    • 7.2.3. By Application
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany gRNA Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product & Services
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Use
    • 7.3.2. France gRNA Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product & Services
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom gRNA Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product & Services
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy gRNA Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product & Services
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain gRNA Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product & Services
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Use

8. Asia Pacific gRNA Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product & Services
    • 8.2.3. By Application
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China gRNA Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product & Services
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Use
    • 8.3.2. India gRNA Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product & Services
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan gRNA Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product & Services
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea gRNA Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product & Services
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia gRNA Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product & Services
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End Use

9. Middle East & Africa gRNA Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product & Services
    • 9.2.3. By Application
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia gRNA Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product & Services
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE gRNA Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product & Services
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa gRNA Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product & Services
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Use

10. South America gRNA Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product & Services
    • 10.2.3. By Application
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil gRNA Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product & Services
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia gRNA Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product & Services
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina gRNA Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product & Services
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global gRNA Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Agilent Technologies, Inc.
  • 15.3. System Biosciences, LLC
  • 15.4. Jena Bioscience GmbH
  • 15.5. Merck KGaA
  • 15.6. Azenta US, Inc.
  • 15.7. Takara Bio, Inc.
  • 15.8. Synbio Technologies
  • 15.9. Revvity, Inc.
  • 15.10. Synthego Corporation

16. Strategic Recommendations

17. About Us & Disclaimer